The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there's multiple different kinds of familial hypercholesterolemia there's monogenic homozygous right these are the worst of the worst this kid by age five has already had a heart attack or stroke subsequent ones later and is dead by age 20
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the monogenic heterozygous is a little bit you know not as bad you know they might get to 25 30